Centers for Disease Control and Prevention

Business Email Compromise (BEC) Market Worth $2.8 Billion By 2027 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Monday, August 15, 2022 - 4:00pm

This trend has been witnessed by cybercriminals or attackers and are finding ways to access email hosted in the cloud.

Key Points: 
  • This trend has been witnessed by cybercriminals or attackers and are finding ways to access email hosted in the cloud.
  • Enterprises are seeking cloud-based BEC solutions to enable cost-effectiveness, rapid deployment, and on-demand access to expertise for mitigating advanced threats on email platforms.
  • Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=162703497
    North America is estimated to account for the highest market share in the BEC market.
  • Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model GEM".

Business Email Compromise (BEC) Market Worth $2.8 Billion By 2027 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Monday, August 15, 2022 - 4:00pm

This trend has been witnessed by cybercriminals or attackers and are finding ways to access email hosted in the cloud.

Key Points: 
  • This trend has been witnessed by cybercriminals or attackers and are finding ways to access email hosted in the cloud.
  • Enterprises are seeking cloud-based BEC solutions to enable cost-effectiveness, rapid deployment, and on-demand access to expertise for mitigating advanced threats on email platforms.
  • Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=162703497
    North America is estimated to account for the highest market share in the BEC market.
  • Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model GEM".

Ginkgo Bioworks and XpresCheck Receive Award to Expand CDC's Traveler-Based SARS-CoV-2 Genomic Surveillance Program In U.S. Airports

Retrieved on: 
Monday, August 15, 2022 - 1:49pm

BOSTON and NEW YORK, Aug. 15, 2022 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) and XpresSpa Group, Inc. (Nasdaq: XSPA) announced they will continue to support the Centers for Disease Control and Prevention's (CDC's) traveler-based SARS-CoV-2 genomic surveillance program through a new contract awarded August 12, 2022. The partnership is expected to support public health and biosecurity services totaling approximately $16 million, with an overall potential to exceed $61 million based on CDC program options and public health priorities. As COVID-19 sublineages and other biological threats continue to emerge, the partners plan to expand the program footprint and incorporate innovative modalities and offerings, such as monitoring of wastewater from aircraft lavatories.

Key Points: 
  • Currently, international travelers arriving at these airports from select countries can enroll in the program on a voluntary basis and be sampled for SARS-CoV-2 for pathogen surveillance purposes.
  • Ginkgo is building a platform to enable customers to program cells as easily as we can program computers.
  • XpresCheck is a leading provider of Covid-19 screening and diagnostic testing with 15 locations in 12 domestic airports.
  • XpresCheck is also partnered with CDC and Concentric by Ginkgo, conducting biosurveillance monitoring in its airport locations to identify existing and new SARS-CoV-2 variants.

Public health experts underscore importance of flu vaccinations to help reduce health inequities among high-risk populations

Retrieved on: 
Friday, August 12, 2022 - 4:00pm

"We have the tools to help reduce the burden of disease in populations most severely affected by flu, especially among those over age 65.

Key Points: 
  • "We have the tools to help reduce the burden of disease in populations most severely affected by flu, especially among those over age 65.
  • As a leader in flu vaccines, Sanofi aims to help protect high-risk populations from flu and its related complications.
  • We have a responsibility to help prevent as much flu as possible through vaccination."
  • "The economic and health burden of vaccine-preventable influenza on communities of color is clear and access to effective vaccines is essential.

California Assemblymember Tom Lackey and Safety Advocates Oppose SB 930 - the Late-Night Bar Bill

Retrieved on: 
Friday, August 12, 2022 - 3:15pm

SACRAMENTO, Calif., Aug. 12, 2022 /PRNewswire/ -- Assemblymember Tom Lackey (R-Palmdale) and safety advocates from Alcohol Justice, and the California Alcohol Policy Alliance (CAPA) gathered at a Capitol press event Wednesday to oppose California SB 930. The "gut & amend" bill, authored by Senator Scott Wiener (D-San Francisco), and Assembly Member Mark Haney (D-San Francisco), is the 5th attempt since 2013 to disrupt the protections of California's statewide, uniform last call.

Key Points: 
  • SACRAMENTO, Calif., Aug. 12, 2022 /PRNewswire/ -- Assemblymember Tom Lackey (R-Palmdale) and safety advocates from Alcohol Justice ,and the California Alcohol Policy Alliance (CAPA) gathered at a Capitol press event Wednesday to oppose California SB 930.
  • "I do not know how legislators who vote yes will reconcile the loss of life," state Assemblymember Lackey.
  • "As a 28-year California Highway Patrol veteran, I have made over 40 death notifications to victims of impaired driving.
  • SB 930 would allow closing times for on-sale retailers to be extended from 2 a.m. to 4 a.m. as part of a dangerous "pilot program."

Mid-Del Schools Improves Air Quality in School Bus Fleet with MERV-13 Equivalent Filtration and UVC by Lumin-Air

Retrieved on: 
Friday, August 12, 2022 - 2:05pm

OKLAHOMA CITY, Aug. 12, 2022 /PRNewswire/ -- The Mid-Del School District is proud to improve the air quality in their school buses.

Key Points: 
  • OKLAHOMA CITY, Aug. 12, 2022 /PRNewswire/ -- The Mid-Del School District is proud to improve the air quality in their school buses.
  • Mid-Del Schools has partnered with Lumin-Air and Midwest Bus Sales to equip their school buses with MERV-13 equivalent filtration and UV-C.
  • The Lumin-Air system continuously filters and disinfects the air recirculated through the school bus HVAC system, helping to reduce contaminants and making students and bus drivers safer.
  • Lumin-Air's solution includes MERV-13 equivalent filtration and UVC lights in an enclosure, which helps reduce contaminants from recirculated air while the buses are occupied.

Standout Gravel Superstar Lauren De Crescenzo Joins Supersapiens as Advisor and Ambassador

Retrieved on: 
Thursday, August 11, 2022 - 3:00pm

Supersapiens, powered by the Abbott Libre Sense Glucose Sport Biosensor, is eager to support De Crescenzo as she tackles gravel racing, time trials, and road cycling.

Key Points: 
  • Supersapiens, powered by the Abbott Libre Sense Glucose Sport Biosensor, is eager to support De Crescenzo as she tackles gravel racing, time trials, and road cycling.
  • De Crescenzo had a breakthrough 2021 season where she was the winningest gravel racer taking the top step of the podium at Unbound Gravel 200, SBT GRVL, Gravel Worlds, and The Rad Fest.
  • "I'm stoked to be a Supersapiens advisor and athlete and be able to use science to unlock even better physical performances.
  • At races like SBT GRVL and Unbound, the Supersapiens ecosystem is a nearly priceless tool," said De Crescenzo.

Fresno City Council Members and Safety Advocates Come Together to Oppose Dangerously Flawed California SB 930 - the 4 a.m. Bar Bill

Retrieved on: 
Wednesday, August 10, 2022 - 2:00am

FRESNO, Calif., Aug. 9, 2022 /PRNewswire/ -- Members of the Fresno City Council joined with health and safety advocates from Alcohol Justice and the Friday Night Live Partnership at Fresno City Hall Tuesday to condemn California SB 930.

Key Points: 
  • FRESNO, Calif., Aug. 9, 2022 /PRNewswire/ -- Members of the Fresno City Council joined with health and safety advocates from Alcohol Justice and the Friday Night Live Partnership at Fresno City Hall Tuesday to condemn California SB 930.
  • The experiment would take place in 6 cities: San Francisco, Oakland, West Hollywood, Cathedral City, Coachella, and Palm Springs.
  • "The effort to keep Fresno bars open until 4 a.m. from 2 a.m. was reckless and dangerous,"said Fresno City Councilmember Gary Bredefeld.
  • That's why several Council colleagues and I are bringing forward a Council resolution on August 11th opposing this stupidity.

Assemblymember Tom Lackey Joins Health and Safety Advocates to Oppose SB 930 - the 4 a.m. Bar Bill

Retrieved on: 
Tuesday, August 9, 2022 - 6:25pm

If the bill becomes law, all surrounding communities of pilot project cities will be threatened by late night drinkers traveling drunk and fatigued into the early morning commute hours.

Key Points: 
  • If the bill becomes law, all surrounding communities of pilot project cities will be threatened by late night drinkers traveling drunk and fatigued into the early morning commute hours.
  • According to the Center for Disease Control (CDC), California currently suffers more annual alcohol-related harm than any other state: 11,000 alcohol-related deaths, $35 billion in total costs, $18.5 billion in state costs.
  • Opposition to SB 930 is growing statewide.
  • Last week, the Los Angeles City Council passed a resolution of opposition , and the powerful Los Angeles County Democratic Party (LACDP) came out against SB 930 in a letter dated June 27, 2022.

Ferring Announces U.S. FDA Advisory Committee Meeting for RBX2660 its Investigational Microbiota-Based Live Biotherapeutic

Retrieved on: 
Tuesday, August 9, 2022 - 12:00pm

The cycle of recurrent CDI represents a significant public health burden, and Ferring is working to address that unmet need.

Key Points: 
  • The cycle of recurrent CDI represents a significant public health burden, and Ferring is working to address that unmet need.
  • The FDA intends to live stream the advisory committee meeting on the agency's YouTube page, and the meeting will also be webcast from the FDA website.
  • RBX2660 has been granted Fast Track, Orphan, and Breakthrough Therapy designations from the U.S. Food and Drug Administration (FDA).
  • Ferring Pharmaceuticals is a research driven, specialty biopharmaceutical group committed to helping people around the world build families and live better lives.